Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Sutherland

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cytometry. Part B, Clinical Cytometry|October 3, 2020
Evaluation of Versalyse as an alternative red blood cell lysing agent in the evaluation of CD34 stem and progenitor cells with the ISHAGE guidelinesLori E Lowes, Benjamin D Hedley, D Robert Sutherland, et al.
Cytometry. Part B, Clinical Cytometry|December 14, 2017
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 3 - data analysis, reporting and case studiesAndrea Illingworth, Iuri Marinov, D Robert Sutherland, et al.
Cancer Genetics and Cytogenetics|January 22, 2004
Interphase cytogenetic analysis of clonality in peripheral blood cells from a patient with Down syndrome and acute megakaryoblastic leukemiaHong Chang, Dan Li, Rakash Nayar, et al.
International Journal of Laboratory Hematology|May 26, 2022
Validation of a single tube 3-colour immature red blood cell screening assay for the detection and enumeration of small, medium and large paroxysmal nocturnal haemoglobinuria clones by flow cytometryIuri Marinov, Stephen J Richards, Adam Pešek, et al.
Cytotherapy|June 11, 2009
Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometersD Robert Sutherland, Rakesh Nayyar, Erica Acton, et al.
Cytometry. Part B, Clinical Cytometry|January 31, 2018
High-sensitivity 5-, 6-, and 7-color PNH WBC assays for both Canto II and Navios platformsD Robert Sutherland, Fernando Ortiz, Graeme Quest, et al.
Annals of the New York Academy of Sciences|June 12, 2003
Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34- hematopoietic and mesenchymal stem cell subsetsChristina Giesert, Anke Marxer, D Robert Sutherland, et al.
Cytometry. Part B, Clinical Cytometry|July 4, 2009
Considerations for the control of background fluorescence in clinical flow cytometryRuud Hulspas, Maurice R G O'Gorman, Brent L Wood, et al.
Current Forestry Reports|October 11, 2022
Centering Indigenous Voices: The Role of Fire in the Boreal Forest of North AmericaAmy Cardinal Christianson, Colin Robert Sutherland, Faisal Moola, et al.
Cytometry. Part B, Clinical Cytometry|November 10, 2019
CD71 improves delineation of PNH type III, PNH type II, and normal immature RBCS in patients with paroxysmal nocturnal hemoglobinuriaD Robert Sutherland, Stephen J Richards, Fernando Ortiz, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cytometry. Part B, Clinical Cytometry|October 3, 2020
Evaluation of Versalyse as an alternative red blood cell lysing agent in the evaluation of CD34 stem and progenitor cells with the ISHAGE guidelinesLori E Lowes, Benjamin D Hedley, D Robert Sutherland, et al.
Cytometry. Part B, Clinical Cytometry|December 14, 2017
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 3 - data analysis, reporting and case studiesAndrea Illingworth, Iuri Marinov, D Robert Sutherland, et al.
Cancer Genetics and Cytogenetics|January 22, 2004
Interphase cytogenetic analysis of clonality in peripheral blood cells from a patient with Down syndrome and acute megakaryoblastic leukemiaHong Chang, Dan Li, Rakash Nayar, et al.
International Journal of Laboratory Hematology|May 26, 2022
Validation of a single tube 3-colour immature red blood cell screening assay for the detection and enumeration of small, medium and large paroxysmal nocturnal haemoglobinuria clones by flow cytometryIuri Marinov, Stephen J Richards, Adam Pešek, et al.
Cytotherapy|June 11, 2009
Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometersD Robert Sutherland, Rakesh Nayyar, Erica Acton, et al.
Cytometry. Part B, Clinical Cytometry|January 31, 2018
High-sensitivity 5-, 6-, and 7-color PNH WBC assays for both Canto II and Navios platformsD Robert Sutherland, Fernando Ortiz, Graeme Quest, et al.
Annals of the New York Academy of Sciences|June 12, 2003
Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34- hematopoietic and mesenchymal stem cell subsetsChristina Giesert, Anke Marxer, D Robert Sutherland, et al.
Cytometry. Part B, Clinical Cytometry|July 4, 2009
Considerations for the control of background fluorescence in clinical flow cytometryRuud Hulspas, Maurice R G O'Gorman, Brent L Wood, et al.
Current Forestry Reports|October 11, 2022
Centering Indigenous Voices: The Role of Fire in the Boreal Forest of North AmericaAmy Cardinal Christianson, Colin Robert Sutherland, Faisal Moola, et al.
Cytometry. Part B, Clinical Cytometry|November 10, 2019
CD71 improves delineation of PNH type III, PNH type II, and normal immature RBCS in patients with paroxysmal nocturnal hemoglobinuriaD Robert Sutherland, Stephen J Richards, Fernando Ortiz, et al.
Pageof 5